TargED closes seed investment for the development of Microlyse – a next-generation thrombolytic clot-busting drug

20201124 Press release TargED FINAL

Allero and Abbreos join forces to develop immunotherapy for COVID-19 patients

20201124_Press release Allero Therapeutics and Abbreos join forces_FINAL-2

Industry veterans Paul Peter Tak and Eric Meldrum join Citryll’s board

Industry veterans Paul Peter Tak and Eric Meldrum join Citryll’s Board

Sirius Medical raises €4.4M in Series A funding to launch Sirius Pintuition

https://www.sirius-medical.com/news/2020/07/13/sirius-medical-raises-e4-4m-in-series-a-funding-to-launch-sirius-pintuition-a-non-radioactive-localization-system-to-improve-breast-cancer-surgery/

Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

https://www.curiecapital.nl/wp-content/uploads/2020/07/Press-release-second-closing-final-2020-Citryll-with-IK.pdf

Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery

https://www.curiecapital.nl/wp-content/uploads/2020/06/001263_SiriusMedicalPR-CErelease.pdf